human AFP protein

RefSeq NM_001134
Also Known As:
AFP protein, human; alpha-fetoprotein, human
Networked: 43 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Stenman, Ulf-Håkan: 2 articles (12/2008 - 01/2008)
2. Lohi, Jouko: 1 article (04/2015)
3. Taskinen, Seppo: 1 article (04/2015)
4. Taskinen, Mervi: 1 article (04/2015)
5. Fagerholm, Riitta: 1 article (04/2015)
6. Evrüke, Cüneyt: 1 article (10/2011)
7. Tunç, Erdal: 1 article (10/2011)
8. İnandiklioğlu, Nihal: 1 article (10/2011)
9. Demirhan, Osman: 1 article (10/2011)
10. Taştemir, Deniz: 1 article (10/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Down Syndrome (Down's Syndrome)
4. Neural Tube Defects (Exencephaly)
07/01/1999 - "To study the detection rates of second trimester ultrasound screening for neural tube defects (NTD), abdominal wall defects (AWD) and Down's syndrome (DS) in low risk populations at tertiary centers, and to compare the ultrasound screening detection rates with those that were obtainable by biochemical serum screening (double test: alpha-fetoprotein/human chorion gonadotrophin/age test). "
06/01/1994 - "Between September 1st 1990 and Juli 31st 1993, 5071 pregnant women were screened prospectively by the "triple-test", including maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol in order to detect chromosomal anomalies and open neural tube defects. "
02/01/2006 - "There are also occasional reports of prenatal diagnosis of IAD by findings on the maternal triple-marker screen (TMST), a combined serum analyte test that measures levels of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol for the detection of Down syndrome and open neural-tube defects. "
04/01/2006 - "Triple test with measured maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol combination as a routine procedure for fetal Down's syndrome, trisomy 18 and neural tube defect screening has some intrinsic problems, such as precision. "
10/01/1994 - "Maternal serum screening (MSS) measures three serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, from which the risk of fetal Down syndrome or open neural tube defect is calculated. "
5. Aneuploidy (Aneuploid)

Related Drugs and Biologics

1. Chorionic Gonadotropin (Human Chorionic Gonadotropin)
2. Estriol (Epiestriol)
3. alpha-Fetoproteins (AFP)
4. Biological Tumor Markers (Tumor Markers)
5. prostatic acid phosphatase
6. inhibin A
7. L-Lactate Dehydrogenase (Lactate Dehydrogenase)
8. Carcinoembryonic Antigen
9. Pregnancy-Specific beta 1-Glycoproteins
10. Placental Lactogen (Human Placental Lactogen)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)